Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast

/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter and full year ended Dec. 31, 2021, and issued its financial outlook...

Related Keywords

China ,India ,Russia ,Brazil ,Abbott Binax ,Robertb Ford , ,International Pediatric Nutrition ,Linkedin ,Us Centers For Medicare Medicaid Services ,Facebook ,Abbott Laboratories ,European Union Medical Device ,Core Laboratory ,Medicaid Services ,Virtual Clinic ,Adult Nutrition ,Pediatric Nutrition ,Molecular Diagnostics ,Rapid Diagnostics ,Emerging Markets ,Medical Devices ,Heart Failure ,Structural Heart ,Diabetes Care ,Neurosphere Virtual Clinic ,Amplatzer Amulet Left Atrial Appendage Occluder ,Aristocrats Index ,Investor Relations ,Private Securities Litigation Reform Act ,Caution Concerning Forward Looking ,Annual Report ,Consolidated Statement ,Quarter Ended December ,Operating Cost ,Continuing Operations ,Discontinued Operations ,Common Share ,Specified Items ,Common Shares ,Dilutive Common Stock Options ,Financial Information From Continuing ,Diluted Earnings ,Ended December ,Cost Reduction Initiatives ,Financial Information From Continuing Operations ,Gross Margin ,European Union ,Medical Device ,Vitro Diagnostics Medical Device ,Abbott ,